A QTc study of cabazitaxel in patients with advanced solid tumors

被引：0
|
作者：
Wade, James Lloyd
Dakhil, Shaker R.
Baron, Ari David
Rottey, Sylvie
Millard, Frederick E.
Daugaard, Gedske
Machiels, Jean-Pascal H.
Conkright, William A.
Sharma, Sunil
Soetekouw, Patricia M. M. B.
Yachnin, Jeffrey
Sengelov, Lisa
van Veldhuizen, Peter
Agarwala, Sanjiv S.
Nguyen, T. X. Quyen
Chadjaa, Mustapha
Maison-Blanche, Pierre
机构：
[1] Canc Care Specialists Cent Illinois, Decatur, IL USA
[2] Canc Ctr Kansas, Wichita, KS USA
[3] Calif Pacific Med Ctr, San Francisco, CA USA
[4] Ghent Univ Hosp, Ghent, Belgium
[5] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[6] Rigshosp, DK-2100 Copenhagen, Denmark
[7] Catholic Univ Louvain, Ctr Canc, B-1200 Brussels, Belgium
[8] Purchase Canc Grp, Paducah, KY USA
[9] Huntsman Canc Inst, Salt Lake City, UT USA
[10] Univ Hosp Maastricht, Maastricht, Netherlands
[11] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[12] Herlev Hosp, DK-2730 Herlev, Denmark
[13] Kansas City Vet Adm Med Ctr, Kansas City, MO USA
[14] St Lukes Canc Ctr, Bethlehem, PA USA
[15] Sanofi, Paris, France
[16] Hop Lariboisiere, F-75475 Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
257
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
    Sehdev, Amikar
    Karrison, Theodore
    Zha, Yuanyuan
    Janisch, Linda
    Turcich, Michelle
    Cohen, Ezra E. W.
    Maitland, Michael
    Polite, Blase N.
    Gajewski, Thomas F.
    Salgia, Ravi
    Pinto, Navin
    Bissonnette, Marc B.
    Fleming, Gini F.
    Ratain, Mark J.
    Sharma, Manish R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 309 - 317
  • [32] A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
    Amikar Sehdev
    Theodore Karrison
    Yuanyuan Zha
    Linda Janisch
    Michelle Turcich
    Ezra E. W. Cohen
    Michael Maitland
    Blase N. Polite
    Thomas F. Gajewski
    Ravi Salgia
    Navin Pinto
    Marc B. Bissonnette
    Gini F. Fleming
    Mark J. Ratain
    Manish R. Sharma
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 309 - 317
  • [33] PHASE I STUDY OF AMATUXIMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Fujisaka, Y.
    Kurata, T.
    Tanaka, K.
    Kudo, T.
    Okamoto, K.
    Tsurutani, J.
    Kaneda, H.
    Kitamura, C.
    Namiki, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2013, 24
  • [34] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Fumoleau, Pierre
    Trigo, Jose Manuel
    Isambert, Nicolas
    Semiond, Dorothee
    Gupta, Sunil
    Campone, Mario
    BMC CANCER, 2013, 13
  • [35] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Pierre Fumoleau
    Jose Manuel Trigo
    Nicolas Isambert
    Dorothée Sémiond
    Sunil Gupta
    Mario Campone
    BMC Cancer, 13
  • [36] Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab
    Agrawal, Shruti
    Waxman, Ian
    Lambert, Alexandre
    Roy, Amit
    Darbenzio, Raymond
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) : 635 - 641
  • [37] Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study
    Nagard, Mats
    Ah-See, Mei-Lin
    Strauss, James
    Wise-Draper, Trisha
    Safran, Howard P.
    Nadeau, Laura
    Edenfield, William J.
    Lewis, Lionel D.
    Rekic, Dinko
    Dota, Corina
    Ottesen, Lone H.
    Li, Yan
    Mugundu, Ganesh M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (02) : 141 - 150
  • [38] Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab
    Shruti Agrawal
    Ian Waxman
    Alexandre Lambert
    Amit Roy
    Raymond Darbenzio
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 635 - 641
  • [39] The effect of tivantinib on QTc interval in subjects with advanced solid tumors and healthy subjects.
    Tachibana, Masaya
    Papadopoulos, Kyriakos P.
    Smith, Lon S.
    Mutz, Danielle
    Mlta, Alain C.
    Mita, Monica M.
    Natale, Ronald B.
    Morganroth, Joel
    Savage, Ronald
    Gajee, Roohl
    Chen, Shuquan
    Zahir, Hamim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study
    Mats Någård
    Mei-Lin Ah-See
    James Strauss
    Trisha Wise-Draper
    Howard P. Safran
    Laura Nadeau
    William J. Edenfield
    Lionel D. Lewis
    Dinko Rekić
    Corina Dota
    Lone H. Ottesen
    Yan Li
    Ganesh M. Mugundu
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 141 - 150
12345